❭

COVID-19 and reactions in the Norwegian population

The aims are to study a representative sample of Norwegian people, their quality of life, stress and coping strategies during the first phase of the corona outbreak in Norway. 

Project leader:

Tine Kristin Grimholt


Links:

Til nettskjema:
Covid-19 og reaksjoner i den norske befolkningen

 
Scroll to top

Home Covid-19 studies

  • Project summary
  • Projects at Oslo University Hospital
  • Multicenter studies (external sponsor)
  • Publications
  • COVID-19 general biobank
  • National overview of covid-19 studies
  • OUS Research Home Page www.ous-research.no

Recent publications

Publications 2025

Hansen BT, Dahl J, Greve-Isdahl M, Winje BA, Rydland KM, Campbell S, Pay ASD, Michelsen TM, Meijerink H (2025)
Low and inequitable influenza and COVID-19 vaccination coverage among pregnant women in Norway: Nationwide population-based cohort study
Vaccine, 61, 127386 (in press)
DOI 10.1016/j.vaccine.2025.127386, PubMed 40517499

Ueland T, Cox RJ, Michelsen AE, Fjelltveit EB, Otterdal K, Dahl T, Zhou F, Elyanow R, Aukrust P, Blomberg B, Halvorsen BE, Langeland N (2025)
Markers of T cell activation and exhaustion in plasma are associated with persistent symptoms up to 18 months following mild SARS-CoV-2 infection
Front Immunol, 16, 1578208
DOI 10.3389/fimmu.2025.1578208, PubMed 40519925

Amstutz A, Schandelmaier S, Ewald H, Speich B, Schwenke JM, Schönenberger CM, Schobinger S, Agoritsas T, Tomashek KM, Nayak S, Makowski M, Morales-Ortega A, Bernal-Bello D, Pomponio G, Ferrarini A, Ghazaeian M, Hall F, Bond S, García-Morales MT, Jiménez-González M, Arribas JR, Guimaraães PO, Tavares CAM, Berwanger O, Yazdanpanah Y et al. (2025)
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials
Lancet Respir Med, 13 (6), 530-544
DOI 10.1016/S2213-2600(25)00055-4, PubMed 40378861

More